nvo market cap 2015 to 2024

On December 31, Novo Nordisk A-S (NVO) had a market capitalization of $383.7B, based on 4.46B shares at a price of $86.02.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
December 2024
$86.02
170,270,800
4,460,500,000
$383,692,210,000.00
November 2024
$106.80
121,022,000
4,460,500,000
$476,381,400,000.00
October 2024
$111.95
108,317,800
4,460,500,000
$499,352,975,000.00
September 2024
$119.07
78,553,700
4,460,500,000
$531,111,735,000.00
August 2024
$139.16
90,131,500
4,460,500,000
$620,723,180,000.00
July 2024
$132.14
92,171,100
4,460,500,000
$589,389,951,700.00
June 2024
$142.21
69,366,700
4,465,400,000
$635,014,263,580.00
May 2024
$134.78
83,584,100
4,465,400,000
$601,826,517,700.00
April 2024
$127.83
79,140,600
4,465,400,000
$570,818,780,100.00
March 2024
$127.92
117,225,100
4,470,500,000
$571,871,724,600.00
February 2024
$118.47
105,942,800
4,470,500,000
$529,613,876,300.00
January 2024
$113.49
96,109,800
4,470,500,000
$507,371,797,650.00
December 2023
$102.33
73,608,100
4,477,400,000
$458,154,432,400.00
November 2023
$100.73
99,919,300
4,477,400,000
$451,024,172,900.00
October 2023
$95.52
113,056,200
4,477,400,000
$427,684,382,180.00
September 2023
$89.95
89,019,100
4,489,000,000
$403,794,079,100.00
August 2023
$91.80
92,845,400
4,489,000,000
$412,097,382,400.00
July 2023
$79.29
48,119,400
4,489,000,000
$355,948,521,500.00
June 2023
$79.65
52,715,800
4,502,600,000
$358,644,697,280.00
May 2023
$78.98
62,124,400
4,502,600,000
$355,608,594,100.00
April 2023
$82.24
54,888,200
4,502,600,000
$370,301,928,680.00
March 2023
$78.33
65,591,000
4,513,200,000
$353,513,540,160.00
February 2023
$68.84
50,562,600
4,513,200,000
$310,705,386,840.00
January 2023
$67.76
60,031,400
4,513,200,000
$305,835,192,720.00
December 2022
$66.08
56,107,600
4,522,800,000
$298,888,785,720.00